Efficacy of every-other-day administration of conjugated equine estrogen and medroxyprogesterone acetate on gonadotropin-releasing hormone agonists treatment in women with endometriosis

Gynecologic and Obstetric Investigation

Volumn 52, Issue 4, 2001, Pages 217-222

  Irahara, Minoru ^a   Uemura, Hirokazu ^a   Yasui, Toshiyuki ^a   Kinoshita, Hiromi ^a   Yamada, Masayo ^a   Tezuka, Michiko ^a   Kiyokawa, Machiko ^a   Kamada, Masaharu ^a   Aono, Toshihiro ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Add back therapy; Endometriosis; GnRH agonist

Indexed keywords

CA 125 ANTIGEN; CONJUGATED ESTROGEN; ESTRADIOL; ESTRONE; GONADORELIN AGONIST; LEUPRORELIN; MEDROXYPROGESTERONE ACETATE;

ADULT; ARTICLE; BLEEDING; BONE ATROPHY; BONE TURNOVER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ENDOMETRIOSIS; ESTRADIOL BLOOD LEVEL; ESTRONE BLOOD LEVEL; FEMALE; GENITAL SYSTEM; HUMAN; JAPAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; ANIMALS; BONE DENSITY; BONE REMODELING; CA-125 ANTIGEN; ENDOMETRIOSIS; ESTRADIOL; ESTROGENS, CONJUGATED (USP); ESTRONE; FEMALE; GONADOTROPIN-RELEASING HORMONE; HORSES; HUMANS; LEUPROLIDE; MEDROXYPROGESTERONE 17-ACETATE; MIDDLE AGED; UTERINE HEMORRHAGE;

EID: 0035208509     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000052978     Document Type: Article

References (20)

1. Modern medical management of endometriosis
2. Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: A randomized placebo-controlled, double-blind study
3. Steroidal treatment of myomas: Preoperative and long-term medical therapy
4. Long-term gonadotropin releasing hormone agonist therapy: The evolving issue of steroidal 'add-back' paradigms
5. 'Add-back' estrogen reverses cognitive deficits induced by a gonadotropin-releasing hormone agonist in women with leiomyomata uteri
6. Effects of oral and transdermal hormone replacement therapy in relation to serum estrogen levels
7. Combination of automatic HPLC-RIA method for determination of estrone and estradiol in serum
8. Gonadotropin-releasing hormone agonists administration in polycystic ovary syndrome: Effects on bone mass
9. Steroidal and nonsteroidal 'add-back' therapy: Extending safety and efficacy of gonadotropin-releasing hormone agonists in the gynecologic patient
10. The role of GnRH agonists plus add-back therapy in the treatment of endometriosis
11. Leuprolide acetate depot and hormonal add-back in endometriosis: A 12-month study
12. Dose-dependent inhibition of pituitary-ovarian function during administration of gonadotropin-releasing hormone agonist analog (nafarelin)
13. A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin 'add-back' regimens for women with leiomyomata uteri
14. Prolonged gonadotropin-releasing hormone agonist treatment of symptomatic endometriosis: The role of cyclic sodium etidronate and low-dose norethindrone 'add-back' therapy
15. Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium
16. Effects of 2 years of hormone replacement upon bone mass, serum lipids and lipoproteins
17. Prevention of postmenopausal bone loss with minimal uterine bleeding using low dose continuous estrogen/progestin therapy: A 2-year prospective study
18. Hormone treatment of endometriosis: The estrogen threshold hypothesis
19. 17β-Estradiol for postmenopausal estrogen replacement therapy
20. Treatment of hot flushes with transdermal estradiol administration